Packeisen J, Korsching E, Herbst H, Boecker W, Buerger H
Department of Pathology, Klinikum Osnabrueck, 49076 Osnabrueck, Germany.
Mol Pathol. 2003 Aug;56(4):198-204. doi: 10.1136/mp.56.4.198.
Several "high throughput methods" have been introduced into research and routine laboratories during the past decade. Providing a new approach to the analysis of genomic alterations and RNA or protein expression patterns, these new techniques generate a plethora of new data in a relatively short time, and promise to deliver clues to the diagnosis and treatment of human cancer. Along with these revolutionary developments, new tools for the interpretation of these large sets of data became necessary and are now widely available. Tissue microarray (TMA) technology is one of these new tools. It is based on the idea of applying miniaturisation and a high throughput approach to the analysis of intact tissues. The potential and the scientific value of TMAs in modern research have been demonstrated in a logarithmically increasing number of studies. The spectrum for additional applications is widening rapidly, and comprises quality control in histotechnology, longterm tissue banking, and the continuing education of pathologists. This review covers the basic technical aspects of TMA production and discusses the current and potential future applications of TMA technology.
在过去十年间,多种“高通量方法”已被引入科研和常规实验室。这些新技术为基因组改变分析以及RNA或蛋白质表达模式研究提供了新途径,能在相对较短时间内产生大量新数据,并有望为人类癌症的诊断和治疗提供线索。随着这些革命性进展,解读这些海量数据集的新工具变得不可或缺,且现已广泛可得。组织微阵列(TMA)技术便是其中一种新工具。它基于将小型化和高通量方法应用于完整组织分析的理念。TMA在现代研究中的潜力和科学价值已在越来越多的研究中得到证明。其额外应用的范围正在迅速扩大,包括组织病理学技术的质量控制、长期组织库建设以及病理学家的继续教育。本综述涵盖了TMA制作的基本技术方面,并讨论了TMA技术当前及未来潜在的应用。